Connect with us

Stelazine (trifluoperazine)

Trifluoperazine (or STELAZINE®) is mainly prescribed to treat schizophrenia and generalized anxiety disorder.

Status: ACTIVE

Class: Typical, Conventional

FDA Approval: 1981

Dosage Forms: 1 mg, 2 mg, 5 mg, 10 mg

Biological Half-life: 10-20 hours

Side Effects: Dizziness, blurred vision, dry mouth, insomnia, muscle weakness, itching or rash, menstrual changes

Routes of Administration: Oral, IM

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.